This study aimed to use CD4+ T cells count as an objective parameter to systematically characterize the evolution of the pathogen profile in bronchoalveolar lavage fluid-targeted next-generation sequencing (BALF-tNGS) from patients with severe pneumonia. This evidence concerns the gene CD4 and susceptibility to pneumonia measurement.